Cytek Biosciences, Inc. EPS (Earnings per Share) 2020–2025
Cytek Biosciences, Inc. reported $0.00 of earnings per share for fiscal 2025. Compared with fiscal 2020, the change was -100.0%.
| Fiscal year | EPS (Earnings per Share) | Change (YoY) |
|---|---|---|
| FY 2025 | $0.00 | — |
| FY 2024 | $0.00 | +100.0% |
| FY 2023 | $-0.09 | -550.0% |
| FY 2022 | $0.02 | — |
| FY 2021 | $0.00 | -100.0% |
| FY 2020 | $0.10 | — |
Source: Cytek Biosciences, Inc. SEC filings — income statement (10-K), split-adjusted. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open CTKB 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Cytek Biosciences, Inc. reported $0.00 of earnings per share for fiscal 2025. Compared with fiscal 2020, the change was -100.0%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Cytek Biosciences, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeCytek Biosciences, Inc. — frequently asked questions
What is Cytek Biosciences, Inc.'s earnings per share?
Cytek Biosciences, Inc. (CTKB) reported earnings per share of $0.00 for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Cytek Biosciences, Inc.'s official SEC filings (income statement (10-K), split-adjusted), refreshed nightly. Not investment advice.